title: Symptomatic Cytomegalovirus Infections in the First Year of Life: When Is Antiviral Therapy Conceived to Be Justified?
abstract: All infants treated with antiviral medication for symptomatic congenital (diagnosis <3 weeks) and probably postnatal (>3 weeks) cytomegalovirus infection were characterized with the help of a survey covering all German Pediatric hospitals between 2012 and 2013. We found that >50% of infants treated for cytomegalovirus were classified as probably postnatal cytomegalovirus infection, which was associated with preterm birth and underlying diseases of the immune system, heart or lung.
authors.affiliation: From the *Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Freiburg, Germany; †Department of Neonatology, University Children's Hospital Tuebingen, 72076 Tuebingen, Germany; and ‡Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Freiburg, Germany.
authors.forename: Katharina
authors.initials: K
authors.lastname: Schuster
authors.forename: Rangmar
authors.initials: R
authors.lastname: Goelz
authors.forename: Carsten
authors.initials: C
authors.lastname: Speckmann
authors.forename: Philipp
authors.initials: P
authors.lastname: Henneke
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000188:drug therapy* / Q000453:epidemiology / Q000821:virology; D005260:Female; D005858:Germany / Q000453:epidemiology; D006776:Hospitals, Pediatric; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011446:Prospective Studies
chemical_list: D000998:Antiviral Agents